Skip to content
Ejaculation.org

Other · 2006

Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation

Modi NB, Dresser MJ, Simon M, Lin D, Desai D, Gupta S (2006). Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation. Journal of Clinical Pharmacology. doi:10.1177/0091270005284850

Key finding
In healthy men, dapoxetine 30 and 60 mg reached peak blood levels about 1 hour after a dose, with an initial half-life of about 1.4 hours; levels fell to about 5% of peak by 24 hours.

Summary

This randomised, two-sequence crossover study in healthy male volunteers measured how dapoxetine is absorbed and eliminated after single and repeated once-daily doses of 30 mg and 60 mg. It was part of the drug's development programme.

Dapoxetine was absorbed rapidly, reaching peak plasma concentrations about 1 hour after a dose. After a single dose, concentrations dropped quickly, to about 5% of the peak by 24 hours. Elimination was biphasic: an initial half-life of about 1.4 hours followed by a terminal half-life of about 20 hours. Repeated dosing did not change the drug's pharmacokinetics, and exposure was proportional to dose. There were no serious adverse events; the most common were diarrhoea, dizziness and nausea.

Limitations

The participants were healthy volunteers, not men with premature ejaculation, and the study measured blood levels rather than effects on ejaculation. It was conducted by the company developing the drug. Daily dosing was used here for measurement purposes, whereas dapoxetine is licensed for on-demand use only.

What it means for you

Dapoxetine is built to act quickly and wear off quickly, which is why it is taken 1 to 3 hours before sex rather than every day. Its effect is tied to that dose; it does not build up in the body to give a lasting change.